Breakthrough pain in chronic non-cancer pain: Fact, fiction, or abuse

Pain Physician

Volumn 14, Issue 2, 2011, Pages

  Manchikanti, Laxmaiah ^a,b   Singh, Vijay ^c   Caraway, David L ^d   Benyamin, Ramsin M ^e,f  

^a PAIN MANAGEMENT CENTER OF PADUCAH   (United States)

^b University of Louisville School of Medicine   (United States)

^c Pain Diagnostics Associates   (United States)

^d St Mary's Pain Relief Center   (United States)

^e MILLENNIUM PAIN CENTER   (United States)

^f UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Addiction; Breakthrough pain; Chronic non cancer pain; Interventional techniques; Opioid abuse; Opioid hyperalgesia; Opioid misuse; Opioids

Indexed keywords

FENTANYL; LONG ACTING DRUG; NARCOTIC ANALGESIC AGENT; SHORT ACTING DRUG;

BREAKTHROUGH PAIN; CHRONIC PAIN; CONSTIPATION; DISEASE EXACERBATION; DRUG ABUSE; DRUG INDICATION; DRUG MEGADOSE; DRUG MISUSE; HUMAN; NAUSEA; PAIN; PRESCRIPTION; REVIEW; SOMNOLENCE; SYSTEMATIC REVIEW;

ANALGESICS, OPIOID; CHRONIC DISEASE; HUMANS; PAIN; PREVALENCE;

EID: 79952849405     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (210)

1. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: A tenyear perspective. Pain Physician 2010; 13:401-435.
2. Okie S. A flood of opioids, a rising tide of deaths. New Engl J Med 2010; 363:1981-1985.
3. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) guidelines. Pain Physician 2008; 11:S5-S62.
4. Chou R, Huffman L. Use of Chronic Opioid Therapy in Chronic Non-cancer Pain: Evidence Review. American Pain Society, Glenview, IL, 2009. http://www.ampainsoc.org/pub/pdf/Opioid_Final_Evidence_Report.pdf
5. Kuehn BM. Opioid prescriptions soar: Increase in legitimate use as well as abuse. JAMA 2007; 297:249-251.
6. Ballantyne JC. Opioid analgesia: Perspectives on right use and utility. Pain Physician 2007; 10:479-491.
7. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300:2613-2620.
8. Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA, Crosby AE. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009; 104:1541-1548.
9. Manchikanti KN, Manchikanti L, Damron KS, Pampati V, Fellows B. Increasing deaths from opioid analgesics in the United States: An evaluation in an interventional pain management practice. J Opioid Manage 2008; 4:271-283.
10. Warner M, Chen LJ, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999--2006. NCHS data brief, no 22. National Center for Health Statistics; Hyattsville, MD: 2009.
11. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009; 181:891-896.
12. Martell BA, O'Connor PG, Kerns RD, Beck WC, Morales KH, Kosten TR, Fiellen DA. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med 2007; 146:116-127.
13. Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings). Rockville, MD. www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf
14. US Department of Health and Human Services. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). Drug Abuse Warning Network, 2008: Area Profiles of Drug-Related Mortality. Rockville, MD, 2010.
15. Manchikanti L, Benyamin R, Datta S, Vallejo R, Smith HS. Opioids in chronic noncancer pain. Expert Rev Neurother 2010; 10:775-789.
16. Kuehn B. Alarming nonfatal overdose rates found for opioids, sedatives, and tranquilizers. JAMA 2010; 303:2020-2021.
17. Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, Fine PG, Foley KM, Gallagher RM, Gilson AM, Haddox JD, Horn SD, Inturrisi CE, Jick SS, Lipman AG, Loeser JD, Noble M, Porter L, Rowbotham MC, Schoelles KM, Turk DC, Volinn E, Von Korff MR, Webster LR, Weisner CM. Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base. Pain 2010; 11:807-829.
18. Silverman SM. Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician 2009; 12:679-684.
19. Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician 2009; 12:507-515.
20. Manchikanti L, Singh V, Boswell MV. Interventional pain management at crossroads: The perfect storm brewing for a new decade of challenges. Pain Physician 2010; 13:E111-E140.
21. Benyamin RM, Datta S, Falco FJE. A perfect storm in interventional pain management: Regulated, but unbalanced. Pain Physician 2010; 13:109-116.
22. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manage 2007; 3:89-100.
23. Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgrad Med 2009; 121:91-102.
24. Evans M, Kriger S, Gunn J, Schwilke G. Effective monitoring of opiates in chronic pain patients. Pract Pain Manag 2009; 9:32-33.
25. Couto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Health Manag 2009; 12:185-190.
26. Gilbert JW, Wheeler GR, Mick GE, Storey BB, Herder SL, Richardson GB, Watts E, Gyarteng-Dakwa K, Marino BS, Kenney CM, Siddiqi M, Broughton PG. Importance of urine drug testing in the treatment of chronic noncancer pain: Implications of recent medicare policy changes in Kentucky. Pain Physician 2010; 13:167-186.
27. Gilbert JW, Wheeler GR, Mick GE, Storey BB, Herder SL, Richardson GB, Watts E, Gyarteng-Dakwa K, Marino BS, Kenney CM, Siddiqi M, Broughton PG. Urine drug testing in the treatment of chronic noncancer pain in a Kentucky private neuroscience practice: The potential effect of Medicare benefit changes in Kentucky. Pain Physician 2010; 13:187-194.
28. Pesce A, Rosenthal M, West R, West C, Mikel C, Almazan P, Latyshev S. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients. Pain Physician 2010; 13:273-281.
29. Pesce A, West C. In response: Numerous studies show urine drug testing a critical tool in treatment of chronic non-cancer pain. Pain Physician 2010; 13:503-504.
30. Pesce A, West C, West R, Crews B, Mikel C, Almazan P, Latyshev S, Rosenthal M, Horn P. Reference intervals: A novel approach to detect drug abuse in a pain patient population. J Opioid Manage 2010; 6:341-350.
31. West R, Pesce A, West C, Crews B, Mikel C, Almazan P, Rosenthal M, Latyshev S. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population. Pain Physician 2010; 13:71-78.
32. West R, Pesce A, West C, Crews B, Mikel C, Rosenthal M, Almazan P, Latyshev S. Observations of medication compliance by measurement of urinary drug concentrations in a pain management population. J Opioid Manage 2010; 6:253-257.
33. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: A prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS). Pain Physician 2010; 13:E1-E22.
34. Manchikanti L, Ailinani H, Koyyalagunta L, Datta S, Singh V, Eriator I, Sehgal N, Shah R, Benyamina RM, Vallejo R, Fellows B, Christo PJ. A systematic review of randomized trials of long-term opioid management for chronic noncancer pain. Pain Physician 2011.
35. Passik SD, Messina J, Golsorkhi A, Xie F. Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage 2011; 41:116-125.
36. Braden JB, Russo J, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010; 170:1425-1432.
37. Katz MH. Long-term opioid treatment of nonmalignant pain: A believer loses his faith. Arch Intern Med 2010; 170:1422-1424.
38. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 2010; 152:85-92.
39. Portenoy R, Bennett DS, Rauck R, Simon S, Taylor D, Brennan M, Shoemaker S. Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain 2006; 7:583-591.
40. Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: Prevalence and characteristics. J Opioid Manag 2010; 6:97-108.
41. Portenoy RK, Bruns D, Shoemaker B, Shoemaker SA. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: Impact on function, mood, and quality of life. J Opioid Manag 2010; 6:109-116.
42. Svendsen KB, Andersen S, Arnason S, Arnér S, Breivik H, Heiskanen T, Kalso E, Kongsgaard UE, Sjogren P, Strang P, Bach FW, Jensen TS. Breakthrough pain in malignant and non-malignant diseases: A review of prevalence, characteristics and mechanisms. Eur J Pain 2005; 9:195-206.
43. Davis MP. Recent development in therapeutics for breakthrough pain. Expert Rev Neurother 2010; 10:757-773.
44. Portenoy RK, Forbes K, Lussier D, Hanks G. Difficult pain problems: An integrated approach. In: Doyle D, Hanks G, Cherny N, Calman K (eds). Oxford Textbook of Palliative Medicine, 3rd Edition. Oxford University Press, Oxford, UK, 2004, pp 438-458.
45. Portenoy RK, Hagen NA. Breakthrough pain: Definition, prevalence and characteristics. Pain 1990; 41:273-281.
46. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: Characteristics and impact in patients with cancer pain. Pain 1999; 81:129-134.
47. Brennan MJ, Stanos S. Strategies to optimize pain management with opioids while minimizing risk of abuse. PM R 2010; 2:544-558.
48. Rodriguez KL, Hanlon JT, Perera S, Jaffe EJ, Sevick MA. A cross-sectional analysis of the prevalence of undertreatment of nonpain symptoms and factors associated with undertreatment in older nursing home hospice/palliative care patients. Am J Geriatr Pharmacother 2010; 8:225-232.
49. Candiotti KA, Gitlin MC. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: Tapentadol, a step toward a solution? Curr Med Res Opin 2010; 26:1677-1684.
50. Fairchild A. Under-treatment of cancer pain. Curr Opin Support Palliat Care 2010; 4:11-15.
51. Claxton RN, Blackhall L, Weisbord SD, Holley JL. Undertreatment of symptoms in patients on maintenance hemodialysis. J Pain Symptom Manage 2010; 39:211-218.
52. Federation of State Medical Boards of the US. Model guidelines for the use of controlled substances for the treatment of pain: A policy document of the Federation of State Medical Boards of the United States, Inc., Dallas, TX, 1998.
53. The American Academy of Pain Medicine; the American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13:6-8.
54. Melzack R. The tragedy of needless pain. Sci Am 1990; 262:27-33.
55. Lamberg L. New guidelines on managing chronic pain in older persons. JAMA 1998; 280:311.
56. Hill CS. Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. J Pain Symptom Manage 1996; 11:287-298.
57. Robinson RC, Gatchel RJ, Polatin P, Deschner M, Noe C, Gajraj N. Screening for problematic prescription opioid use. Clin J Pain 2001; 17:220-228.
58. National Opioids Use Guideline Group (NOUGG). Canadian guidelines for safe and effective use of opioids for chronic non-cancer pain, Version 5.6. April 2010. http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_b_v5_6.pdf
59. Narasimhaswamy S, Vedi C, Xavier Y, Tseng CH, Shine D. Effect of implementing pain management standards. J Gen Intern Med 2006; 21:689-693.
60. Should healthcare providers screen for pain as the fifth vital sign? How about some evidence? The Back Letter 2010; 25:133, 139-141.
61. Schiavenato M, Craig KD. Pain assessment as a social transaction. Clin J Pain 2010; 26:667-676.
62. Lucas CE, Vlahos AL, Ledgerwood AM. Kindness kills: The negative impact of pain as the fifth vital sign. J Am Coll Surg 2007; 205:101-107.
63. Mularski RA, White-Chu F, Overbay D, Miller L, Asch SM, Ganzini L. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006; 21:607-612.
64. Phillips DM. JCAHO pain management standards are unveiled. Joint Commission on Accreditation of Healthcare Organizations. JAMA 2000; 284:428-429.
65. Bennett DS, Simon S, Brennan M, Shoemaker SA. Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics. J Opioid Manag 2007; 3:101-106.
66. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; CD006605.
67. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, Mannion AF, Reis S, Staal JB, Ursin H, Zanoli G; COST B13 Working Group on Guidelines for Chronic Low Back Pain. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006; 15: S192-S300.
68. British Pain Society. Opioids for persistent pain: Good practice. A consensus statement prepared on behalf of the British Pain Society, the Faculty of Pain Medicine and the Royal College of Anaesthetists, the Royal College of General Practitioners and the Faculty of Addictions of the Royal College of Psychiatrists. The British Pain Society; London, UK: January 2010.
69. Papaleontious M, Hederson CR. Turner BJ, Moore AA, Olkhovskaya Y, Amanfo L, Reid MC. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: A systematic review and meta-analysis. J Am Geriatr Soc 2010; 58:1353-1369.
70. Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008; 8:287-313.
71. Colson J, Koyyalagunta D, Hayek SM, Balog C, Manchikanti L. A systematic review of observational studies on the effectiveness of opioid therapy for cancer pain. Pain Physician 2011.
72. Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011.
73. Christo PJ, Manchikanti L, Ruan X, Hansen H, Solanki DR, Jordan AE, Colson J. Urine drug testing in chronic pain. Pain Physician 2011.
74. Manchikanti L, Manchikanti KN, Pampati V, Cash KA. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009; 12:259-267.
75. Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009; 13:331-338.
76. Mercadante S, Radbruch L, Caraceni N, Cherny N, Kaasa S, Nauck F, Ripamonti C, De Conno F; Steering Committee of the European Association for Palliative Care (EAPC) Research Network. Episodic (breakthrough) pain. Consensus Conference of an Expert Working Group of the European Association for Palliative Care. Cancer 2002; 94:832-839.
77. Goncalves JA. The importance of a word: How to translate "breakthrough. " Palliat Med 2008; 22:195.
78. Zeppetella G. Opioids for cancer breakthrough pain: A pilot study reporting patient assessment of time to meaningful pain relief. J Pain Symptom Manage 2008; 35:563-567.
79. Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev 2006; 1:CD004311.
80. McCarberg BH. The treatment of breakthrough pain. Pain Med 2007; 8:S8-S13.
81. Mishra S, Bhatnagar S, Chaudhary P, Rana SP. Breakthrough cancer pain: Review of prevalence, characteristics and management. Indian J Palliat Care 2009; 15:14-18.
82. Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, Jackson KA, Lickiss N, Muirden N, Pisasale M, Moulin D, Schulz VN, Rico Pazo MA, Serrano JA, Andersen H, Henriksen HT, Mejholm I, Sjogren P, Heiskanen T, Kalso E, Pere P, Poyhia R, Vuorinen E, Tigerstedt I, Ruismaki P, Bertolino M, Larue F, Ranchere JY, Hege-Scheuing G, Bowdler I, Helbing F, Kostner E, Radbruch L, Kastrinaki K, Shah S, Vijayaram S, Sharma KS, Devi PS, Jain PN, Ramamani PV, Beny A, Brunelli C, Maltoni M, Mercadante S, Plancarte R, Schug S, Engstrand P, Ovalle AF, Wang X, Alves MF, Abrunhosa MR, Sun WZ, Zhang L, Gazizov A, Vaisman M, Rudoy S, Gomez Sancho M, Vila P, Trelis J, Chaudakshetrin P, Koh ML, Van Dongen RT, Vielvoye-Kerkmeer A, Boswell MV, Elliott T, Hargus E, Lutz L; Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med 2004; 18:177-183.
83. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice. J Pain Symp Manage 2000; 20:87-92.
84. Zeppetella G, Ribeiro MD. The pharmacotherapy of cancer-related episodic pain. Expert Opin Pharmacother 2003; 4:493-502.
85. Hwang SS, Chang VT, Kasimis B. Cancer breakthrough pain characteristics and responses to treatment at a VA medical center. Pain 2003; 101:55-64.
86. Fine PG, Busch MA. Characterization of breakthrough pain by hospice patients and their caregivers. Pain Symp Manage 1998; 16:179-183.
87. Hagen NA, Stiles C, Nekolaichuk C, Biondo P, Carlson LE, Fisher K, Fainsinger R. The Alberta Breakthrough Pain Assessment Tool for cancer patients: A validation study using a Delphi process and patient think-aloud interviews. J Pain Symptom Manage 2008; 35:136-152.
88. Carr DB, Goudas LC, Denman WT, Brookoff D, Staats PS, Brennen L, Green G, Albin R, Hamilton D, Rogers MC, Firestone L, Lavin PT, Mermelstein F. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: A randomized, double-blind, placebo-controlled, crossover study. Pain 2004; 108:17-27.
89. Coluzzi PH. Cancer pain management: Newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care 1998; 15:13-22.
90. McQuay HJ, Jadad AR. Incident pain. Cancer Surv 1994; 21:1724.
91. Farrar JT, Polomano RC, Berlin JA, Strom BL. A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity. Anesthesiology 2010; 112:1464-1472.
92. Fine PG, Messina J, Xie F, Rathmell J. Long-term safety and tolerability of fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic pain: An 18-month study. J Pain Symptom Manage 2010; 40:747-760.
93. Webster LR. Breakthrough pain in the management of chronic persistent pain syndromes. Am J Manag Care 2008; 14: S116-S122.
94. Devulder J, Jacobs A, Richarz U, Wiggett H. Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth 2009; 103:576-585.
95. Portenoy RK, Messina J, Xie F, Peppin J. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: A randomized, placebo-controlled study. Curr Med Res Opin 2007; 23:223-233.
96. Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006; 22:1859-1865.
97. Manchikanti L. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 1: Introduction and general considerations. Pain Physician 2008; 11:161-186.
98. Manchikanti L, Hirsch JA, Smith HS. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 2: Randomized controlled trials. Pain Physician 2008; 11:717-773.
99. Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 3: Systematic reviews and meta-analysis of randomized trials. Pain Physician 2009; 12:35-72.
100. Manchikanti L, Singh V, Smith HS, Hirsch JA. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: Part 4: Observational studies. Pain Physician 2009; 12:73-108.
101. Manchikanti L, Derby R, Wolfer LR, Singh V, Datta S, Hirsch JA. Evidencebased medicine, systematic reviews, and guidelines in interventional pain management: Part 5. Diagnostic accuracy studies. Pain Physician 2009; 12:517-540.
102. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of met-analyses. Lancet 1999; 354:1896-1900.
103. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009; 151:W65-W94.
104. van Tulder M, Furlan A, Bombardier C, Bouter L; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine (Phila Pa 1976) 2003; 28:1290-1299.
105. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Metaanalysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-2012.
106. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T; CONSORT GROUP (Consolidated Standards of Reporting Trials). The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 2001; 134:663-694.
107. Moher D, Schulz KF, Altman D, for the CONSORT Group. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285:1987-1991.
108. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Ann Intern Med 2007; 147:573-577.
109. Manchikanti L. Singh V, Datta S, Cohen SP, Hirsch JA. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009; 12: E35-E70.
110. Bonica JJ. Definitions and taxonomy of pain. In: Bonica JJ, Loessor JD, Chapman CR, Fordyce WE (eds). The Management of Pain, Second Edition. Lea & Febiger, Philadelphia, 1990, pp 18-27.
111. Smith BH, Gribbin M. Etiology, prevention, treatment, and disability management of chronic pain. Introduction. Clin J Pain 2001; 17:S1-S4.
112. Rucker KS. Chronic Pain Evaluation. Butterworth/Heinemann, Boston 2001.
113. Coccharella L, Andersson GBJ (eds). Pain. In: Guides to the Evaluation of Permanent Impairment, Fifth Edition. American Medical Association, Chicago, IL, 2000, pp 565-591.
114. Rondinelli R (ed). Guide to the Evaluation of Permanent Impairment, 6th ed. American Medical Association, Chicago, 2008.
115. Petzke F, Radbruch L, Sabatowski R, Karthaus M, Mertens A. Slow-release tramadol for treatment of chronic malignant pain-an open multicenter trial. Support Care Cancer 2001; 9:48-54.
116. Hanks GW, Portenoy RK, MacDonald N, Forbes K. Difficult pain problems. In Doyle D, Hanks GW, MacDonald N (eds). Oxford Textbook of Pallitative Medicine. Oxford University Press, New York, 1998, pp 454-476.
117. Petzke F, Radbruch L, Zech D, Loick G, Grond S. Temporal presentation of chronic cancer pain: Transitory pains on admission to a multidisciplinary pain clinic. J Pain Symptom Manage 1999; 17:391-401.
118. Roth SH. Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis. J Rheumatol 1998; 25:1358-1363.
119. Cousins M. Acute and postoperative pain. In: Wall PD, Melzack R (eds). Textbook of Pain, Third Edition. Churchill Livingstone, New York, 1994, pp 357-385.
120. Zeppetella G, O'Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Palliative Med 2001; 15:243-246.
121. Bruera E, Schoeller T, Wenk R, MacEachern T, Marcelino S, Hanson J, Suarez-Almazor M. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 1995; 10:348-355.
122. Vogt MT, Kwoh CK, Cope DK, Osial TA, Culyba M, Starz TW. Analgesic usage for low back pain: Impact on health care costs and service use. Spine (Phila Pa 1976) 2005; 30:1075-1081.
123. Luo X, Pietrobon R, Hey L. Patterns and trends in opioid use among individuals with back pain in the United States. Spine (Phila Pa 1976) 2004; 29:884-891.
124. Franklin GM, Stover BD, Turner JA, Fulton-Kehoe D, Wickizer TM; Disability Risk Identification Study Cohort. Early opioid prescription and subsequent disability among workers with back injuries: The Disability Risk Identification Study Cohort. Spine (Phila Pa 1976) 2008; 33:199-204.
125. Mahmud MA, Webster BS, Courtney TK, Matz S, Tacci JA, Christiani DC. Clinical management and the duration of disability for work-related low back pain. J Occup Environ Med 2000; 42:1178-1187.
126. Webster BS, Verma SK, Gatchel RJ. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery, and late opioid use. Spine (Phila Pa 1976) 2007; 32:2127-2132.
127. Fillingim RB, Doleys DM, Edwards RR, Lowery D. Clinical characteristics of chronic back pain as a function of gender and oral opioid use. Spine (Phila Pa 1976) 2003; 28:143-150.
128. Rhee Y, Taitel MS, Walker DR, Lau DT. Narcotic drug use among patients with lower back pain in employer health plans: A retrospective analysis of risk factors and health care services. Clin Ther 2007; 29:2603-2612.
129. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 2006; 10:287-333.
130. Eriksen J, Sjøgren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain. An epidemiological study. Pain 2006; 125:172-179.
131. Bernstein D, Stowell AW, Haggard R, Worzer W, Polatin PB, Gatchel RJ. Complex interplay of participants in opioid therapy. Pract Pain Manage 2007; 7:10-36.
132. Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am 2009; 91:919-927.
133. Sjøgren P, Grønbæk M, Peuckmann V, Ekholm O. A population-based cohort study on chronic pain: The role of opioids. Clin J Pain 2010; 26:763-769.
134. Eriksen J, Jensen MK, Sjøgren P, Ekholm O, Rasmussen NK. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003; 106:221-228.
135. Taylor DR, Webster LR, Chun SY, Reinking J, Stegman M, Shoemaker S, Fortner B. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ). Pain Med 2007; 8:281-288.
136. Abernethy AP, Wheeler JL, Fortner BV. A health economic model of breakthrough pain. Am J Manag Care 2008; 14:S129-S140.
137. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK. Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001; 91:123-130.
138. Farrar JT, Clearly J, Rauck R, Busch M, Nordbrock E. Oral transmucosal fentanyl citrate: Randomized, doubleblinded, placebo-controlled trials for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998; 90:611-616.
139. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. Pain 1999; 82:263-274.
140. Davies AN, Vriens J, Kennett A, McTaggart M. An observational study of oncology patients' utilization of breakthrough pain medication. J Pain Symptom Manage 2008; 35:406-411.
141. Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, Mangione S. Intravenous morphine for breakthrough (episodic) pain in an acute palliative care unit: A confirmatory study. J Pain Symptom Manage 2008; 35:307-313.
142. Portenoy RK, Taylor D, Messina J, Tremmel L. A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain 2006; 22:805-811.
143. Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician 2008; 11:S105-S120.
144. Trescot AM, Datta S, Glaser S, Sehgal N, Hansen H, Benyamin R, Patel S. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008; 11:S181-S200.
145. Edrington J, Sun A, Wong C, Dodd M, Padilla G, Paul S, Miaskowski C. Barriers to pain management in a community sample of Chinese American patients with cancer. J Pain Symptom Manage 2009; 37:665-765.
146. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008; 19:1985-1991.
147. Popenhagen MP. Collaborative practice. Undertreatment of pain and fears of addiction in pediatric chronic pain patients: How do we stop the problem? J Spec Pediatr Nurs 2006; 11:61-67.
148. O'Malley P. The undertreatment of pain: Ethical and legal implications for the clinical nurse specialist. Clin Nurse Spec 2005; 19:236-237.
149. Stalnikowicz R, Mahamid R, Kaspi S, Brezis M. Undertreatment of acute pain in the emergency department: A challenge. Int J Qual Health Care 2005; 17:173-176.
150. Primm BJ, Perez L, Dennis GC, Benjamin L, Clark W, Keough K, Leak WD, Payne R, Smith D, Sullivan LW; National Medical Association. Managing pain: The challenge in underserved populations: Appropriate use versus abuse and diversion. J Natl Med Assoc 2004; 96:1152-1161.
151. Dahl JL, Bennett ME, Bromley MD, Joranson DE. Success of the state pain initiatives: Moving pain management forward. Cancer Pract 2002; 10:S9-S13.
152. Frank-Stromborg M, Christensen A. A serious look at the undertreatment of pain: Part I. Clin J Oncol Nurs 2001; 5:235-236.
153. Frank-Stromborg M, Christensen A. A serious look at the undertreatment of pain: Part II. Clin J Oncol Nurs 2001; 5:276-278.
154. Cleeland CS. Undertreatment of cancer pain in elderly patients. JAMA 1998; 279:1914-1915.
155. Resnik DB, Rehm M, Minard RB. The undertreatment of pain: Scientific, clinical, cultural, and philosophical factors. Med Health Care Philos 2001; 4:277-288.
156. Sutters KA, Miaskowski C. Inadequate pain management and associated morbidity in children at home after tonsillectomy. J Pediatr Nurs 1997; 12:178-185.
157. Passik SD, Squire P. Current risk assessment and management paradigms: Snapshots in the life of the pain specialist. Pain Medicine 2009; 10: S101-S114.
158. Tsao JC, Stein JA, Dobalian A. Sex differences in pain and misuse of prescription analgesics among persons with HIV. Pain Medicine 2010; 11:815-824.
159. Richeimer SH. Are we lemmings going off a cliff? The case against the "interventional" pain medicine label. Pain Med 2010; 11:3-5.
160. Caraway DL, Kloth D, Hirsch JA, Deer TE, Datta S, Helm S. In response to: Are we lemmings going off a cliff? The case against the "interventional" pain medicine label. Pain Med 2010; 11:1303-1304.
161. Taylor DR. Reply to Dr. Richeimer's "are we lemmings going off a cliff?" Pain Med 2010; 11:1745.
162. Gallagher RM. Response to Donald R. Taylor on "are we lemmings going off a cliff?" Pain Med 2010; 11:1746.
163. Hadjistavropoulos T, Marchildon GP, Fine PG, Herr K, Palley HA, Kaasalainen S, Béland F. Transforming long-term care pain management in North America: The policy-clinical interface. Pain Medicine 2009; 10:506-520.
164. Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): A public law for balancing treatment of pain and drug abuse and diversion. Pain Physician 2005; 8:335-347.
165. Manchikanti L. Prescription drug abuse: What is being done to address this new drug epidemic? Testimony before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources. Pain Physician 2006; 9:287-321.
166. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S, Buenaventura RM, Conn A, Datta S, Derby R, Falco FJE, Erhart S, Diwan S, Hayek SM, Helm S, Parr AT, Schultz DM, Smith HS, Wolfer LR, Hirsch JA. Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician 2009; 12:699-802.
167. Freburger JK, Holmes GM, Agans RP, Jackman AM, Darter JD, Wallace AS, Castel LD, Kalsbeek WD, Carey TS. The rising prevalence of chronic low back pain. Arch Intern Med 2009; 169:251-258.
168. Manchikanti L, Boswell MV, Singh V, Derby R, Fellows B, Falco FJE, Datta S, Smith HS, Hirsch JA. Comprehensive review of neurophysiologic basis and diagnostic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E71-E120.
169. Manchikanti L, Boswell MV, Datta S, Fellows B, Abdi S, Singh V, Benyamin RM, Falco FJE, Helm S, Hayek S, Smith HS. Comprehensive review of therapeutic interventions in managing chronic spinal pain. Pain Physician 2009; 12:E123-E198.
170. Manchikanti L, Helm S, Singh V, Benyamin RM, Datta S, Hayek S, Fellows B, Boswell MV. An algorithmic approach for clinical management of chronic spinal pain. Pain Physician 2009; 12:E225-E264.
171. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 1. Basic considerations. Pain Physician 2010; 13:E23-E54.
172. Manchikanti L, Falco FJE, Boswell MV, Hirsch JA. Facts, fallacies, and politics of comparative effectiveness research: Part 2. Implications for interventional pain management. Pain Physician 2010; 13:E55-E79.
173. Manchikanti L, Datta S, Derby R, Wolfer LR, Benyamin RM, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 1. Diagnostic interventions. Pain Physician 2010; 13: E141-E174.
174. Manchikanti L, Datta S, Gupta S, Munglani R, Bryce DA, Ward SP, Benyamin RM, Sharma ML, Helm II S, Fellows B, Hirsch JA. A critical review of the American Pain Society clinical practice guidelines for interventional techniques: Part 2. Therapeutic interventions. Pain Physician 2010; 13:E215-E264.
175. Falco FJE, Erhart S, Wargo BW, Bryce DA, Atluri S, Datta S, Hayek SM. Systematic review of diagnostic utility and therapeutic effectiveness of cervical facet joint interventions. Pain Physician 2009; 12:323-344.
176. Datta S, Lee M, Falco FJE, Bryce DA, Hayek SM. Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009; 12:437-460.
177. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of lumbar facet joint nerve blocks in managing chronic low back pain: A randomized, double-blind, controlled trial with a 2-year follow-up. Int J Med Sci 2010; 7:124-135.
178. Manchikanti L, Singh V, Falco FJE, Cash KA, Fellows B. Comparative outcomes of a 2-year follow-up of cervical medial branch blocks in management of chronic neck pain: A randomized, double-blind controlled trial. Pain Physician 2010; 13:437-450.
179. Manchikanti L, Dunbar EE, Wargo BW, Shah RV, Derby R, Cohen SP. Systematic review of cervical discography as a diagnostic test for chronic spinal pain. Pain Physician 2009; 12:305-321.
180. Manchikanti L, Glaser S, Wolfer L, Derby R, Cohen SP. Systematic review of lumbar discography as a diagnostic test for chronic low back pain. Pain Physician 2009; 12:541-559.
181. Conn A, Buenaventura R, Datta S, Abdi S, Diwan S. Systematic review of caudal epidural injections in the management of chronic low back pain. Pain Physician 2009; 12:109-135.
182. Parr AT, Diwan S, Abdi S. Lumbar interlaminar epidural injections in managing chronic low back and lower extremity pain: A systematic review. Pain Physician 2009; 12:163-188.
183. Benyamin RM, Singh V, Parr AT, Conn A, Diwan S, Abdi S. Systematic review of the effectiveness of cervical epidurals in the management of chronic neck pain. Pain Physician 2009; 12:137-157.
184. Buenaventura RM, Datta S, Abdi S, Smith HS. Systematic review of therapeutic lumbar transforaminal epidural steroid injections. Pain Physician 2009; 12:233-251.
185. Helm S, Hayek S, Benyamin RM, Manchikanti L. Systematic review of the effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician 2009; 12:207-232.
186. Frey ME, Manchikanti L, Benyamin RM, Schultz DM, Smith HS, Cohen SP. Spinal cord stimulation for patients with failed back surgery syndrome: A systematic review. Pain Physician 2009; 12:379-397.
187. Epter RS, Helm S, Hayek SM, Benyamin RM, Smith HS, Abdi S. Systematic review of percutaneous adhesiolysis and management of chronic low back pain in post lumbar surgery syndrome. Pain Physician 2009; 12:361-378.
188. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009; 12:345-360.
189. Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP. Evaluation of sacroiliac joint interventions: A systematic appraisal of the literature. Pain Physician 2009; 12:399-418.
190. Hayek SM, Helm S, Benyamin RM, Singh V, Bryce DA, Smith HS. Effectiveness of spinal endoscopic adhesiolysis in post lumbar surgery syndrome: A systematic review. Pain Physician 2009; 12:419-435.
191. Hirsch JA, Singh V, Falco FJE, Benyamin RM, Manchikanti L. Automated percutaneous lumbar discectomy for the contained herniated lumbar disc: A systematic assessment of evidence. Pain Physician 2009; 12:601-620.
192. Singh V, Manchikanti L, Benyamin RM, Helm S, Hirsch JA. Percutaneous lumbar laser disc decompression: A systematic review of current evidence. Pain Physician 2009; 12:573-588.
193. Singh V, Benyamin RM, Datta S, Falco FJE, Helm S, Manchikanti L. Systematic review of percutaneous lumbar mechanical disc decompression utilizing Dekompressor. Pain Physician 2009; 12:589-599.
194. Manchikanti L, Derby R, Benyamin RM, Helm S, Hirsch JA. A systematic review of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2009; 12:561-572.
195. Manchikanti L, Singh V, Falco FJ, Cash KA, Fellows B. Cervical medial branch blocks for chronic cervical facet joint pain: A randomized double-blind, controlled trial with one-year follow-up. Spine (Phila Pa 1976) 2008; 33:1813-1820.
196. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V, Fellows B. Comparative effectiveness of a one-year followup of thoracic medial branch blocks in management of chronic thoracic pain: A randomized, double-blind active controlled trial. Pain Physician 2010; 13:535-548.
197. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin RM. A preliminary report of a randomized doubleblind, active controlled trial of fluoroscopic thoracic interlaminar epidural injections in managing chronic thoracic pain. Pain Physician 2010; 13:E357-E369.
198. Manchikanti L, Singh V, Cash KA, Datta S. Management of pain of post lumbar surgery syndrome: One-year results of a randomized, double-blind, active controlled trial of fluoroscopic caudal epidural injections. Pain Physician 2010; 13:509-521.
199. Manchikanti L, Cash KA, McManus CD, Pampati V, Singh V, Benyamin RM. The preliminary results of a comparative effectiveness evaluation of adhesiolysis and caudal epidural injections in managing chronic low back pain secondary to spinal stenosis: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E341-E354.
200. Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. A comparative effectiveness evaluation of percutaneous adhesiolysis and epidural steroid injections in managing lumbar post surgery syndrome: A randomized, equivalence controlled trial. Pain Physician 2009; 12:E355-E368.
201. Manchikanti L, Singh V, Falco FJE, Cash KA, Pampati V. Evaluation of the effectiveness of lumbar interlaminar epidural injections in managing chronic pain of lumbar disc herniation or radiculitis: A randomized, double-blind, controlled trial. Pain Physician 2010; 13:343-355.
202. Manchikanti L, Cash KA, McManus CD, Pampati V, Benyamin R. Preliminary results of a randomized, double-blind, controlled trial of fluoroscopic lumbar interlaminar epidural injections in managing chronic lumbar discogenic pain without disc herniation or radiculitis. Pain Physician 2010; 13:E279-E292.
203. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. Cervical epidural injections in chronic discogenic neck pain without disc herniation or radiculitis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:E265-E278.
204. Manchikanti L, Cash KA, Pampati V, Wargo BW, Malla Y. The effectiveness of fluoroscopic cervical interlaminar epidural injections in managing chronic cervical disc herniation and radiculitis: Preliminary results of a randomized, double-blind, controlled trial. Pain Physician 2010; 13:223-236.
205. Deer TR, Smith HS, Cousins M, Doleys DM, Levy RM, Rathmell JP, Staats PS, Wallace MS, Webster LR. Consensus guidelines for the selection and implantation of patients with noncancer pain for intrathecal drug delivery. Pain Physician 2010; 13:E175-E213.
206. Gerges FJ, Lipsitz SR, Nedeljkovic SS. A systematic review on the effectiveness of the nucleoplasty procedure for discogenic pain. Pain Physician 2010; 13:117-132.
207. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain In US: 1980 versus 2000. Pain 2004; 109:514-519.
208. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18:1166-1175.
209. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study. Pain 2008; 138:440-449.
210. Franklin GM, Rahman EA, Turner JA, Danielle WE, Fulton-Kehoe D. Opioid use for chronic low back pain. A prospective, population-based study among injured workers in Washington state, 2002-2005. Clin J Pain 2009; 25:743-751.